从17000点到27000点！“9.24”行情这一年：港股“造富神话”能否继续？

Core Viewpoint - The Hong Kong stock market has experienced significant volatility over the past year, with the Hang Seng Index rising from approximately 17,000 points to over 27,000 points, marking a new high since 2022, driven by sectors such as AI, innovative pharmaceuticals, and new consumption [1][4][10]. Market Performance - The Hang Seng Index closed at 26,159 points, down 0.7%, while the Hang Seng Tech Index closed at 6,167 points, down 1.45% as of September 23 [1]. - The market has shown a "first strong, then slow, and then rebound" trend throughout the year, with the Hang Seng Index outperforming A-shares in the first half but lagging behind in July and August [6][10]. Sector Analysis - The technology sector, particularly in AI and innovative pharmaceuticals, has seen substantial gains, with stocks like SMIC rising over 120% and Alibaba increasing by over 90% [7]. - The innovative pharmaceutical sector has also gained traction, with companies like Innovent Biologics and BeiGene making significant international partnerships [7][11]. Market Dynamics - The Hong Kong stock market has seen a surge in liquidity, with average daily trading volume reaching 240.2 billion HKD in the first half of the year, a 118% increase year-on-year [4]. - The number of IPOs has increased significantly, with 51 IPOs raising 128 billion HKD in the first seven months of the year, surpassing the total for the previous year [9]. Future Outlook - Analysts remain optimistic about the future of the Hong Kong stock market, citing the potential for continued valuation recovery in sectors like technology and non-essential consumption [10][14]. - The market is expected to experience further upward movement, driven by structural industry recovery and the ongoing liquidity cycle [13][14].